The Food and Drug Administration is sounding the warning bell on counterfeit versions of the weight loss medication Ozempic, saying fakes cause possible infection risks.

The agency said it has seized thousands of units of the product, which has crept its way into the legitimate U.S. drug supply chain. 

Skip to content